Literature DB >> 3318674

The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis.

L W Riley1.   

Abstract

Entities:  

Mesh:

Year:  1987        PMID: 3318674     DOI: 10.1146/annurev.mi.41.100187.002123

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


× No keyword cloud information.
  39 in total

1.  Relationship of genetic type of Shiga toxin to manifestation of bloody diarrhea due to enterohemorrhagic Escherichia coli serogroup O157 isolates in Osaka City, Japan.

Authors:  Y Nishikawa; Z Zhou; A Hase; J Ogasawara; T Cheasty; K Haruki
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Characterization of the distal tail fiber locus and determination of the receptor for phage AR1, which specifically infects Escherichia coli O157:H7.

Authors:  S L Yu; K L Ko; C S Chen; Y C Chang; W J Syu
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

3.  Escherichia coli O157:H7 infections associated with perforated appendicitis and chronic diarrhoea.

Authors:  N Cimolai; J D Anderson; N M Bhanji; L Chen; G K Blair
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

4.  Rapid Immunoassay for detection of Escherichia coli O157 directly from stool specimens.

Authors:  C H Park; N M Vandel; D L Hixon
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

5.  Antibiotic susceptibility of enterohemorrhagic Escherichia coli O157:H7 isolated from an outbreak in Japan in 1996.

Authors:  I Tsuboi; H Ida; E Yoshikawa; S Hiyoshi; E Yamaji; I Nakayama; T Nonomiya; F Shigenobu; M Shimizu; K O'Hara; T Sawai; K Mizuoka
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

6.  Production of Shiga-like toxin among Escherichia coli strains and other bacteria isolated from diarrhea in São Paulo, Brazil.

Authors:  R Giraldi; B E Guth; L R Trabulsi
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome.

Authors:  H Chart; S M Scotland; H R Smith; B Rowe
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

8.  Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157.

Authors:  A Thomas; H R Smith; B Rowe
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

9.  Environmental regulation of the long polar fimbriae 2 of enterohemorrhagic Escherichia coli O157:H7.

Authors:  Margarita M Arenas-Hernández; Maricarmen Rojas-López; Abraham Medrano-López; Karen J Nuñez-Reza; José Luis Puente; Ygnacio Martínez-Laguna; Alfredo G Torres
Journal:  FEMS Microbiol Lett       Date:  2014-07-17       Impact factor: 2.742

10.  Virulence properties of Escherichia coli strains belonging to serogroups O26, O55, O111 and O128 isolated in the United Kingdom in 1991 from patients with diarrhoea.

Authors:  S M Scotland; G A Willshaw; H R Smith; B Said; N Stokes; B Rowe
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.